<DOC>
	<DOCNO>NCT01199380</DOCNO>
	<brief_summary>Depression related vulnerability highly comorbid smoke behavior dramatically reduce cessation rate among community clinical sample . Previous research examine efficacy cognitive-behavioral treatment individual history major depressive disorder ( MDD ) standard cessation treatment . A broad health impact achieve target individual current elevate depressive symptom address association cessation failure . Thus objective present proposal conduct Stage II randomize control trial ( RCT ) compare behavioral activation intervention standard treatment among similar community sample 200 adult smoker elevate depressive symptom . Participants follow 52 week post-quit date large sample size allow complex analysis cessation outcome .</brief_summary>
	<brief_title>Behavioral Activation Intervention Smoking Cessation Smokers With Depressive Symptoms</brief_title>
	<detailed_description>This Stage II randomize control trial examine efficacy behavioral activation treatment smoking ( BATS ) vs. standard smoke cessation treatment ( ST ) . We recruit 200 smoker elevate depressive symptom randomize one two treatment group . Treatment deliver group format across BATS ( n = 100 ) ST condition ( n = 100 ) . All participant receive 8 week transdermal nicotine patch addition assign treatment group . We intend compare BA treatment smoking ( BATS ) standard smoke cessation intervention ( ST ) abstinence relapse outcome . In addition examine extent depressive symptom reward sensitivity prior quit date mediate effect BATS improve smoke cessation outcomes relative ST .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Between 18 65 year age A regular smoker least one year Currently smoke average least 10 cigarette per day Want quit smoke Report current elevate depressive symptom Current Axis I disorder Psychoactive substance dependence ( exclude nicotine dependence ) within past 6 month Current use psychotropic medication participation form psychotherapy A history significant medical condition ( e.g. , cardiovascular , neurological , gastrointestinal ) , pregnancy and/or breast feeding , systemic illness Current use pharmacotherapy smoke cessation provide researcher quit attempt</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Smoking , Smoking Cessation</keyword>
</DOC>